多年来,我们用复方樟柳碱治疗缺血性视神经病变、缺血性视网膜及脉络膜病变,均能改善眼的微循环,改善眼供血,提高视功能,已为大量临床实践及动物实验所证实。但近几年由于樟柳碱药源困难,因此寻找代替樟柳碱的任务,迫在眉睫。鉴于樟柳碱与山莨菪碱(6542)同属莨菪类生物硷,从1987年1月,我们对6例缺血性视神经病变及5例缺血性视网膜脉络膜病 Over the years, we use compound anisodine treatment of ischemic optic neuropathy, ischemic retinal and choroidal lesions, can improve the microcirculation of the eye, improve eye blood supply, improve visual function, has been confirmed for a large number of clinical and animal experiments . But in recent years due to anisodine drug source difficulties, so looking for an alternative to anisodine task, imminent. As anisodine and anisodamine (6542) belong to the class of alkaloids alkaloids, from January 1987, we have 6 cases of ischemic optic neuropathy and 5 cases of ischemic retinal choroidopathy